New insights on GLP-1 drugs: Benefits and risks unveiled
HQ Team January 21, 2024: The popular diabetes drugs, glucagon-like peptide-1 (GLP-1) receptor agonists such as Ozempic, have gained immense popularity for their.
Drugs
Pharma
Research
Health
Pharma
Research
Beyond body mass index, experts hone in on new definition of obesity
Obesity, as defined by the standard body mass index, is erroneous, and the condition should be split into two — pre-clinical and clinical,.
Drugs
Health
Research
Effects of loneliness, social isolation leave their mark on blood: Cambridge study
Loneliness may contribute to a higher risk of heart disease, stroke and susceptibility to infections, according to a study conducted by the University.
Drugs
Health
Medical
AstraZeneca in $1.92 million deal with HK-listed CSPC Pharmaceutical
British-Swedish AstraZeneca signed a $1.92 billion licensing agreement with CSPC Pharmaceutical Group to develop, manufacture and commercialize a compound to treat a metabolic.
Drugs
Health
Medical
Covid-19 vaccines increase life expectancy of heart patients, study
HQ Team May 13, 2024: New research says Covid-19 vaccines given to people suffering from heart failure improve their chances of living longer.
Drugs
Health
Medical
Ultra-Processed Foods linked to over 30 adverse health outcomes
Bharti Jayshankar February 29, 2024: From packaged snacks to sugary drinks, the allure of ultra-processed foods (UPF) has become a staple in many.
Drugs
Health
Medical
The loneliness epidemic: A pervasive global health crisis
HQ Team February 21,2024: Loneliness is a pervasive epidemic affecting the youngest to the oldest, impacting their physical and mental health alike. As.
Climate
Health
Medical
Uncovering hidden costs of lead exposure: New study
HQ Team November 21, 2023: Lead exposure remains a significant worldwide health risk, and a study has quantified its toll on both health.
Climate
Health
Pharma
Global air pollution wrecking human resistance to antibiotics
HQ Team August 13, 2023: Global air pollution can aid antibiotic resistance in humans, researchers from China and the UK found. They checked.
Drugs
Health
Pharma
Roche, Alnylam to jointly develop hypertension therapy
HQ Team July 25, 2023: Switzerland’s healthcare company, Roche, signed a pact with US-based Alnylam to jointly develop and commercialize a therapy to.